Mariam Kayle1, Sharron L Docherty2, Richard Sloane3, Paula Tanabe2, Gary Maslow4, Wei Pan5, Nirmish Shah6. 1. Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States. 2. School of Nursing, School of Medicine, Duke University, Durham, North Carolina, United States. 3. Geriatric Research, Education, and Clinical Center, Durham Veterans Affairs Medical Center, Durham, North Carolina, United States. 4. School of Medicine, School of Nursing, Duke University, Durham, North Carolina, United States. 5. School of Nursing, Duke University, Durham, North Carolina, United States. 6. School of Medicine, Duke University, Durham, North Carolina, United States.
Abstract
BACKGROUND: Sickle cell disease (SCD) is a chronic blood disorder in which mortality has increased for adolescents and young adults (AYA). PROCEDURE: A longitudinal analysis of medical records was conducted to describe the clinical course among AYAs (ages 12-27 years) during transition to adult care. Measures included sociodemographic, complications, SCD severity (modified pediatric SCD severity index), comorbidities, and transfer. Group-based trajectory modeling (GBTM) to identify subgroups with distinct severity trajectories and chi-square and unpaired Student t test to explore subgroup differences were used. RESULTS: Overall, 339 AYAs (97% black, 56% male, 69% hemoglobin SS) had 10 848 clinic, 3840 hospital, and 3152 emergency department visits. Complications included vaso-occlusive crises (80%) and acute chest syndrome (41%). Comorbidities included depression (19%) and anxiety (14%). Most AYAs transferred to adult care (n = 220) at 19 years. Fourteen AYAs died, 10 within seven years from transfer. GBTM identified both stable and increasing severity trajectory groups: stable-low (n = 31, 23%), stable-medium (n = 61, 46%), stable-high (n = 6, 4.5%), low-increasing (n = 13, 10%), and medium-increasing (n = 22, 17%). AYAs with increasing severity (25%) were older, lived closer to the clinic, and had higher risk for SCD complications and comorbidities. They had fewer pediatric clinic visits; however, they were more likely to transfer and remain longer in adult SCD care. CONCLUSIONS: Whereas most AYAs had stable severity, nearly a quarter had increasing severity, over time. AYAs with increasing severity had more complications, were more likely to transfer to adult care, and demonstrated higher and longer adult SCD care utilization compared with AYAs with stable severity.
BACKGROUND:Sickle cell disease (SCD) is a chronic blood disorder in which mortality has increased for adolescents and young adults (AYA). PROCEDURE: A longitudinal analysis of medical records was conducted to describe the clinical course among AYAs (ages 12-27 years) during transition to adult care. Measures included sociodemographic, complications, SCD severity (modified pediatric SCD severity index), comorbidities, and transfer. Group-based trajectory modeling (GBTM) to identify subgroups with distinct severity trajectories and chi-square and unpaired Student t test to explore subgroup differences were used. RESULTS: Overall, 339 AYAs (97% black, 56% male, 69% hemoglobin SS) had 10 848 clinic, 3840 hospital, and 3152 emergency department visits. Complications included vaso-occlusive crises (80%) and acute chest syndrome (41%). Comorbidities included depression (19%) and anxiety (14%). Most AYAs transferred to adult care (n = 220) at 19 years. Fourteen AYAs died, 10 within seven years from transfer. GBTM identified both stable and increasing severity trajectory groups: stable-low (n = 31, 23%), stable-medium (n = 61, 46%), stable-high (n = 6, 4.5%), low-increasing (n = 13, 10%), and medium-increasing (n = 22, 17%). AYAs with increasing severity (25%) were older, lived closer to the clinic, and had higher risk for SCD complications and comorbidities. They had fewer pediatric clinic visits; however, they were more likely to transfer and remain longer in adult SCD care. CONCLUSIONS: Whereas most AYAs had stable severity, nearly a quarter had increasing severity, over time. AYAs with increasing severity had more complications, were more likely to transfer to adult care, and demonstrated higher and longer adult SCD care utilization compared with AYAs with stable severity.
Authors: Xandra W van den Tweel; Johanna H van der Lee; Harriët Heijboer; Marjolein Peters; Karin Fijnvandraat Journal: Am J Hematol Date: 2010-10 Impact factor: 10.047
Authors: Deepika S Darbari; Onyinye Onyekwere; Mehdi Nouraie; Caterina P Minniti; Lori Luchtman-Jones; Sohail Rana; Craig Sable; Gregory Ensing; Niti Dham; Andrew Campbell; Manuel Arteta; Mark T Gladwin; Oswaldo Castro; James G Taylor; Gregory J Kato; Victor Gordeuk Journal: J Pediatr Date: 2011-09-03 Impact factor: 4.406
Authors: James L Levenson; Donna K McClish; Bassam A Dahman; Viktor E Bovbjerg; Vanessa de A Citero; Lynne T Penberthy; Imoigele P Aisiku; John D Roberts; Susan D Roseff; Wally R Smith Journal: Psychosom Med Date: 2007-12-24 Impact factor: 4.312
Authors: Mary E Keenan; Megan Loew; Kristoffer S Berlin; Jason Hodges; Nicole M Alberts; Jane S Hankins; Jerlym S Porter Journal: J Pediatr Psychol Date: 2021-03-18
Authors: Grace Champlin; Scott N Hwang; Andrew Heitzer; Juan Ding; Lisa Jacola; Jeremie H Estepp; Winfred Wang; Kenneth I Ataga; Curtis L Owens; Justin Newman; Allison A King; Robert Davis; Guolian Kang; Jane S Hankins Journal: Exp Biol Med (Maywood) Date: 2021-08-18
Authors: Kyleigh Schraeder; Alberto Nettel-Aguirre; Andrew S Mackie; Kerry McBrien; Olesya Barrett; Gina Dimitropoulos; Susan Samuel Journal: Can Fam Physician Date: 2022-05 Impact factor: 3.025
Authors: Nancy Crego; Christian Douglas; Emily Bonnabeau; Marian Earls; Kern Eason; Elizabeth Merwin; Gary Rains; Paula Tanabe; Nirmish Shah Journal: J Am Board Fam Med Date: 2020 Jan-Feb Impact factor: 2.657
Authors: Anjelica C Saulsberry-Abate; Marita Partanen; Jerlym S Porter; Pradeep S B Podila; Jason R Hodges; Allison A King; Winfred C Wang; Jane E Schreiber; Xiwen Zhao; Guolian Kang; Lisa M Jacola; Jane S Hankins Journal: Br J Haematol Date: 2021-02-11 Impact factor: 6.998
Authors: Kristen E Howell; Anjelica C Saulsberry-Abate; Joacy G Mathias; Jerlym S Porter; Jason R Hodges; Kenneth I Ataga; Sheila Anderson; Vikki Nolan; Jane S Hankins Journal: Pediatr Blood Cancer Date: 2021-07-19 Impact factor: 3.838
Authors: Nicole M Alberts; Sherif M Badawy; Jerlym S Porter; Jane S Hankins; Jason Hodges; Jeremie H Estepp; Chinonyelum Nwosu; Hamda Khan; Matthew P Smeltzer; Ramin Homayouni; Sarah Norell; Lisa Klesges Journal: JMIR Mhealth Uhealth Date: 2020-05-08 Impact factor: 4.773
Authors: Abdulaziz Mohammad Al-Sharydah; Mohammed Alshahrani; Bander Aldhaferi; Afnan Fahad Al-Muhanna; Hanadi Al-Thani Journal: Saudi J Med Med Sci Date: 2019-04-12